| Code | 5225E | ||||||||||
| MA number | 18/0001/24-S | ||||||||||
| Product Form: | tbl flm 196 (2x98)x50 mg/1 000 mg (blis.PVC/PE/PVDC/Al - viacn.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Vipharm S.A., Poland | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 21 | ||||||||||
| Container: | blister PVC/PE/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.01.2024 |
| Validity: | 20.01.2029 |
| PIL: |
PIL_Ansifora Duo 50 mg_1000 mg_tbl flm_01_2024.pdf
|
| SPC: |
SPC_Ansifora Duo 50 mg_1000 mg_tbl flm_01_2024.pdf
|
| Safety feature | Yes |
| Data update: | 25.01.2024 |
